New agents for Gram-positive bacteria

被引：63

作者：

Bhavnani, SM ^{[1
]}

Ballow, CH

机构：

[1] Kaleida Hlth Millard Fillmore Hosp, Clin Pharmacokinet Lab, Buffalo, NY 14209 USA

[2] SUNY Buffalo, Sch Pharm, Buffalo, NY 14209 USA

来源：

CURRENT OPINION IN MICROBIOLOGY | 2000年 / 3卷 / 05期

关键词：

D O I：

10.1016/S1369-5274(00)00134-X

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Infections caused by multiple-resistant Gram-positive organisms continue to occur at an alarming rate worldwide. Two new and unique antimicrobial agents targeted specifically against such organisms, quinupristin/dalfopristin and linezolid, have been approved for use in the USA in the past year and will play an important role in the treatment of life-threatening infections. In addition, several new fluoroquinolones have been approved recently or will be available in the near future to aid in the treatment of infections caused by resistant strains of Streptococcus pneumoniae.

引用

页码：528 / 534

页数：7

共 77 条

[1] DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS
ALBORN, WE
ALLEN, NE
PRESTON, DA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) : 2282 - 2287
[2] Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (Linezolid):: New treatment options for infections due to resistant organisms
Antony, SJ
Bitter, KM
Moreland, T
Raudales, F
Diaz-Luna, H
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1341 - 1342
[3] BALL P, 2000, M125 3 EUR C CHEM MA
[4] BALLOW CH, 2000, INT C MACR AZ STREPT
[5] BARMAN B, 1999, DRUGS, V57, P363
[6] BARMAN BJA, 2000, DRUGS, V59, P116
[7] Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
Bauernfeind, A
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) : 639 - 651
[8] Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates
Bell, JM
Paton, JC
Turnidge, J
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) : 2187 - 2190
[9] BAY 12-8039, a novel fluoroquinolone activity against important respiratory tract pathogens
Biedenbach, DJ
Barrett, MS
Croco, MAT
Jones, RN
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (01) : 45 - 50
[10] BIRMINGHAM MC, 1999, 37 INF DIS SOC AM AN

← 1 2 3 4 5 6 7 8 →